Abstract
Hyperexcitability of and aberrant spontaneous impulse generation by damaged first-order sensory neurons and their peripheral axons are well-established processes that strongly contribute to pain associated with diabetic neuropathy. Studies in the past 5 years, however, suggest that, as in many neuropathic pain disorders, central neuropathic mechanisms can also contribute to pain experienced with diabetes. These studies have demonstrated that thalamic dysfunction occurs in patients with diabetes mellitus, and that in experimental models of this disease neurons in the ventral posterolateral thalamus can become hyperexcitable, firing at abnormally high frequencies and generating aberrant spontaneous activity. In this article, we discuss these findings, which suggest that thalamic neurons can act as central generators or amplifiers of pain in diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tavakoli, M. & Malik, R. A. Management of painful diabetic neuropathy. Expert Opin. Pharmacother. 9, 2969–2978 (2008).
Jose, V. M., Bhansali, A., Hota, D. & Pandhi, P. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabet. Med. 24, 377–383 (2007).
Morello, C. M., Leckband, S. G., Stoner, C. P., Moorhouse, D. F. & Sahagian, G. A. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch. Intern. Med. 159, 1931–1937 (1999).
Ahlgren, S. C., White, D. M. & Levine, J. D. Increased responsiveness of sensory neurons in the saphenous nerve of the streptozotocin-diabetic rat. J. Neurophysiol. 68, 2077–2085 (1992).
Burchiel, K. J., Russell, L. C., Lee, R. P. & Sima, A. A. Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. A possible mechanism of chronic diabetic neuropathic pain. Diabetes 34, 1210–1213 (1985).
Misawa, S. et al. Neuropathic pain is associated with increased nodal persistent Na+ currents in human diabetic neuropathy. J. Peripher. Nerv. Syst. 14, 279–284 (2009).
Craner, M. J., Klein, J. P., Renganathan, M., Black, J. A. & Waxman, S. G. Changes of sodium channel expression in experimental painful diabetic neuropathy. Ann. Neurol. 52, 786–792 (2002).
Hong, S., Morrow, T. J., Paulson, P. E., Isom, L. L. & Wiley, J. W. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J. Biol. Chem. 279, 29341–29350 (2004).
Hains, B. C., Saab, C. Y., Klein, J. P., Craner, M. J. & Waxman, S. G. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J. Neurosci. 24, 4832–4839 (2004).
Selvarajah, D. et al. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia 51, 2088–2092 (2008).
Sorensen, L., Siddall, P. J., Trenell, M. I. & Yue, D. K. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy. Diabetes Care 31, 980–981 (2008).
Wood, P. B. Role of central dopamine in pain and analgesia. Expert Rev. Neurother. 8, 781–797 (2008).
Cauda, F. et al. Altered resting state in diabetic neuropathic pain. PLoS ONE 4, e4542 (2009).
Paulson, P. E., Wiley, J. W. & Morrow, T. J. Concurrent activation of the somatosensory forebrain and deactivation of periaqueductal gray associated with diabetes-induced neuropathic pain. Exp. Neurol. 208, 305–313 (2007).
Fischer, T. Z., Tan, A. M. & Waxman, S. G. Thalamic neuron hyperexcitability and enlarged receptive fields in the STZ model of diabetic pain. Brain Res. 1268, 154–161 (2009).
Guilbaud, G., Benoist, J. M., Jazat, F. & Gautron, M. Neuronal responsiveness in the ventrobasal thalamic complex of rats with an experimental peripheral mononeuropathy. J. Neurophysiol. 64, 1537–1554 (1990).
Miki, K. et al. Dorsal column–thalamic pathway is involved in thalamic hyperexcitability following peripheral nerve injury: a lesion study in rats with experimental mononeuropathy. Pain 85, 263–271 (2000).
Zhao, P., Waxman, S. G. & Hains, B. C. Sodium channel expression in the ventral posterolateral nucleus of the thalamus after peripheral nerve injury. Mol. Pain 2, 27 (2006).
Wodarski, R., Clark, A. K., Grist, J., Marchand, F. & Malcangio, M. Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats. Eur. J. Pain 13, 807–811 (2008).
Luo, Y., Kaur, C. & Ling, E. A. Neuronal and glial response in the rat hypothalamus-neurohypophysis complex with streptozotocin-induced diabetes. Brain Res. 925, 42–54 (2002).
Vinik, A. Clinical review: use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J. Clin. Endocrinol. Metab. 90, 4936–4945 (2005).
Chang, Y. W., Tan, A., Saab, C. & Waxman, S. Unilateral focal burn injury is followed by long-standing bilateral allodynia and neuronal hyperexcitability in spinal cord dorsal horn. J. Pain 11, 119–130 (2009).
Hains, B. C. & Waxman, S. G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 26, 4308–4317 (2006).
Jin, S. X., Zhuang, Z. Y., Woolf, C. J. & Ji, R. R. p38 Mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 4017–4022 (2003).
McMahon, S. B., Cafferty, W. B. & Marchand, F. Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192, 444–462 (2005).
Watkins, L. R., Milligan, E. D. & Maier, S. F. Glial activation: a driving force for pathologicalpain. Trends Neurosci. 24, 450–455 (2001).
Zhao, P., Waxman, S. G. & Hains, B. C. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J. Neurosci. 27, 2357–2368 (2007).
Zhao, P., Waxman, S. G. & Hains, B. C. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J. Neurosci. 27, 8893–8902 (2007).
Misawa, S. et al. Axonal potassium conductance and glycemic control in human diabetic nerves. Clin. Neurophysiol. 116, 1181–1187 (2005).
Latham, J. R. et al. Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes 58, 2656–2665 (2009).
Messinger, R. B. et al. In vivo silencing of the CaV3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 145, 184–195 (2009).
Wei, H., Hämäläinen, M. M., Saarnilehto, M., Koivisto, A. & Pertovaara, A. Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals. Anesthesiology 111, 147–154 (2009).
Lunn, M. P., Hughes, R. A. & Wiffen, P. J. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database of Systematic Reviews, Issue 4, Art. No.: CD007115. doi:10.1002/14651858.CD007115.pub2 (2009).
Bansal, D., Bhansali, A., Hota, D., Chakrabarti, A. & Dutta, P. Amitriptyline vs pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial. Diabet. Med. 26, 1019–1026 (2009).
Wymer, J. P., Simpson, J., Sen, D. & Bongardt, S. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin. J. Pain 25, 376–385 (2009).
Tan, A. M. et al. Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury. J. Neurosci. 28, 13173–13183 (2008).
Rush, A. M., Cummins, T. R. & Waxman, S. G. Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J. Physiol. 579, 1–14 (2007).
Acknowledgements
This work was supported in part by the Rehabilitation Research Service and the Medical Research Service, US Department of Veterans Affairs, and the Erythromelalgia Association. The Center for Neuroscience and Regeneration Research is a collaboration of the Paralyzed Veterans of America and the United Spinal Association with Yale University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Fischer, T., Waxman, S. Neuropathic pain in diabetes—evidence for a central mechanism. Nat Rev Neurol 6, 462–466 (2010). https://doi.org/10.1038/nrneurol.2010.90
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2010.90
This article is cited by
-
Two nested syndromes: fibromyalgia and neuropathic pain in prediabetes—a pilot study
International Journal of Diabetes in Developing Countries (2022)
-
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Nature Reviews Endocrinology (2021)
-
Status of peripheral sodium channel blockers for non-addictive pain treatment
Nature Reviews Neurology (2020)
-
Non-invasive neuromodulation effects on painful diabetic peripheral neuropathy: a systematic review and meta-analysis
Scientific Reports (2020)
-
Transcranial direct current stimulation improves quality of life and physical fitness in diabetic polyneuropathy: a pilot double blind randomized controlled trial
Journal of Diabetes & Metabolic Disorders (2020)